Your browser doesn't support javascript.
loading
Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2.
Chen, Yeh; Yang, Wen-Hao; Chen, Hsiao-Fan; Huang, Li-Min; Gao, Jing-Yan; Lin, Cheng-Wen; Wang, Yu-Chuan; Yang, Chia-Shin; Liu, Yi-Liang; Hou, Mei-Hui; Tsai, Chia-Ling; Chou, Yi-Zhen; Huang, Bao-Yue; Hung, Chian-Fang; Hung, Yu-Lin; Wang, Wei-Jan; Su, Wen-Chi; Kumar, Vathan; Wu, Yu-Chieh; Chao, Shih-Wei; Chang, Chih-Shiang; Chen, Jin-Shing; Chiang, Yu-Ping; Cho, Der-Yang; Jeng, Long-Bin; Tsai, Chang-Hai; Hung, Mien-Chie.
Afiliação
  • Chen Y; Institute of New Drug Development, China Medical University, Taichung, Taiwan; Drug Development Center, China Medical University, Taichung, Taiwan; Research Center for Cancer Biology, China Medical University, Taichung, Taiwan. Electronic address: bluecrystalprotein@gmail.com.
  • Yang WH; Drug Development Center, China Medical University, Taichung, Taiwan; Research Center for Cancer Biology, China Medical University, Taichung, Taiwan; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan; Center for Molecular Medicine, China Medical University, Taichun
  • Chen HF; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
  • Huang LM; Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Gao JY; Drug Development Center, China Medical University, Taichung, Taiwan; School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan.
  • Lin CW; Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan; Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, Taiwan.
  • Wang YC; Institute of New Drug Development, China Medical University, Taichung, Taiwan.
  • Yang CS; Institute of New Drug Development, China Medical University, Taichung, Taiwan.
  • Liu YL; Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.
  • Hou MH; Institute of New Drug Development, China Medical University, Taichung, Taiwan.
  • Tsai CL; Institute of New Drug Development, China Medical University, Taichung, Taiwan.
  • Chou YZ; Institute of New Drug Development, China Medical University, Taichung, Taiwan.
  • Huang BY; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
  • Hung CF; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
  • Hung YL; Program of Digital Health Innovation, China Medical University, Taichung, Taiwan.
  • Wang WJ; Research Center for Cancer Biology, China Medical University, Taichung, Taiwan; Department of Biological Science and Technology, China Medical University, Taichung, Taiwan.
  • Su WC; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
  • Kumar V; Drug Development Center, China Medical University, Taichung, Taiwan.
  • Wu YC; School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan.
  • Chao SW; Drug Development Center, China Medical University, Taichung, Taiwan.
  • Chang CS; Drug Development Center, China Medical University, Taichung, Taiwan; School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan.
  • Chen JS; Department of Surgery, College of Medicine, National Taiwan University Hospital and National Taiwan University, Taipei, Taiwan.
  • Chiang YP; Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Cho DY; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan; Department of Neurosurgery, China Medical University Hospital, Taichung, Taiwan.
  • Jeng LB; School of Medicine, China Medical University, Taichung, Taiwan; Department of Surgery, China Medical University Hospital, China Medical University, Taichung, Taiwan.
  • Tsai CH; School of Medicine, China Medical University, Taichung, Taiwan; China Medical University Children's Hospital, China Medical University, Taichung, Taiwan.
  • Hung MC; Drug Development Center, China Medical University, Taichung, Taiwan; Research Center for Cancer Biology, China Medical University, Taichung, Taiwan; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan; Center for Molecular Medicine, China Medical University, Taichun
J Biol Chem ; 298(3): 101658, 2022 03.
Article em En | MEDLINE | ID: mdl-35101449
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Proteases 3C de Coronavírus / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 / Aminoquinolinas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Proteases 3C de Coronavírus / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 / Aminoquinolinas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article